Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PECAM-1 (CD31) expression modulates bleeding time in vivo.

S Mahooti1, D Graesser, S Patil

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.

The American Journal of Pathology
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus study to support and enhance Parkinson's disease management.

Journal of Parkinson's disease·2026
Same author

The impact of inclusive electron ion collider data on the strong coupling determination in a global PDF fit.

The European physical journal. C, Particles and fields·2026
Same author

Patient and family perceptions of a discharge bedside board.

PEC innovation·2023
Same author

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.

BMC neurology·2022
Same author

Correction to 'The phantom chorus: birdsong boosts human well-being in protected areas'.

Proceedings. Biological sciences·2021
Same author

Porous and strong three-dimensional carbon nanotube coated ceramic scaffolds for tissue engineering.

Journal of materials chemistry. B·2020

Platelet endothelial cell adhesion molecule-1 (PECAM-1) deficiency causes prolonged bleeding in mice. Endothelial PECAM-1, not platelet PECAM-1, is crucial for regulating blood clotting and preventing excessive bleeding.

Area of Science:

  • Immunology
  • Vascular Biology
  • Hematology

Background:

  • Platelet endothelial cell adhesion molecule-1 (PECAM-1) is an Ig superfamily member expressed on blood and endothelial cells.
  • PECAM-1 acts as an adhesion and signaling molecule, influencing angiogenesis, cell migration, and leukocyte transmigration.
  • Previous studies suggested PECAM-1's role in thrombosis, but in vitro platelet aggregation in deficient mice showed no abnormalities.

Purpose of the Study:

  • To investigate the in vivo role of PECAM-1 in bleeding and thrombosis.
  • To determine whether PECAM-1's function in bleeding is mediated by hematopoietic or endothelial cells.

Main Methods:

  • Assessed bleeding times in PECAM-1-deficient mice.
  • Performed bone marrow transplantation experiments using wild-type and PECAM-1-deficient hematopoietic precursors and recipients.

Related Experiment Videos

  • Evaluated the contribution of endothelial versus hematopoietic cell PECAM-1 to hemostasis.

    • Main Results:

    • PECAM-1-deficient mice exhibited significantly prolonged in vivo bleeding times.
    • Engraftment of wild-type hematopoietic precursors into PECAM-1-deficient mice did not correct the prolonged bleeding.
    • Engraftment of PECAM-1-deficient hematopoietic precursors into wild-type mice resulted in normal bleeding times, indicating endothelial PECAM-1 is critical.

    Conclusions:

    • Endothelial cell-expressed PECAM-1 plays a critical role in modulating in vivo thrombosis and hemostasis.
    • Hematopoietic cell-derived PECAM-1 is not essential for regulating bleeding times.
    • These findings highlight the importance of endothelial PECAM-1 in vascular health and bleeding regulation.